Docetaxel (Taxotere) as monotherapy in the treatment of hormone- refractory prostate cancer: Preliminary results

J. Picus, M. Schultz

Research output: Contribution to journalReview articlepeer-review

255 Scopus citations

Fingerprint

Dive into the research topics of 'Docetaxel (Taxotere) as monotherapy in the treatment of hormone- refractory prostate cancer: Preliminary results'. Together they form a unique fingerprint.

Medicine & Life Sciences